Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

29.22
0.0000
Volume:45
Turnover:1.32K
Market Cap:584.45K
PE:- -
High:29.22
Open:29.22
Low:29.22
Close:29.22
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.06
T/O Rate:0.22%
Dividend:0.08
Dividend Rate:0.29%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Sep 14

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Sep 14

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Sep 14

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Sep 14

J&J Shares up 1.2% Premarket After Report Co's Orthopedics Unit Draws Apollo Interest in Potential $20 Bln Deal

THOMSON REUTERS
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Sep 14

J&J - Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Nsclc

THOMSON REUTERS
·
Sep 14

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Sep 14

Johnson & Johnson in Advanced Talks to Sell Orthopaedics Unit to Apollo in Potential $20B Deal

Deep News
·
Sep 13

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
Sep 12

J&J Orthopedics Unit Draws Apollo Interest in Potential $20 Billion Deal, Bloomberg News Reports

Reuters
·
Sep 12

Apollo Global is Said in Talks to Acquire J&J’s Orthopedics Unit - Bloomberg News

THOMSON REUTERS
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

AbbVie Announces Q4 2026 Dividend of R$ 0.37 Per Unit, Payable Nov. 23

Reuters
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

TIPRANKS
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11